Prescribing overview
Human trazodone labeling does not establish an approved animal behavioral indication or regimen. Sedation alone does not demonstrate relief of distress.
Key prescribing checks
- Screen the full medication list for other serotonergic drugs and monoamine oxidase inhibitors. The human label warns about serotonin syndrome and clinically important interactions.
- Sedation and impaired coordination are relevant observations to document. Do not assume increased sleepiness proves that anxiety or distress is adequately controlled.
- Review cardiac history and drugs affecting cardiac rhythm with the clinician; the human label describes arrhythmia and QT-related risks. Animal-specific decisions require veterinary references.
Uses by species
Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.
Veterinary patients: not established by reviewed label
Extra-label veterinary use; reviewed tablets are human-labeledVeterinarian-selected behavioral or situational management
Human approval is for major depressive disorder, not an animal protocol.
Use / indication source ↗Pharmacology & pharmacokinetics
Mechanism and clinical role
Inhibits serotonin reuptake and antagonizes 5-HT2 receptors; alpha-1 antagonism contributes to hypotension risk.
Absorption, distribution, metabolism and elimination
Reviewed human-label PK does not verify animal absorption, active-metabolite exposure or elimination intervals.
SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC
Contraindications & cautions
Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.
Desyrel
Human tablet brand identity; Human product
Contraindications · when not to use
- MAOI treatment or use within fourteen days, including linezolid or intravenous methylene blue.
Precautions & monitoring
- Arrhythmia/QT prolongation, hypotension, sedation and hyponatremia require assessment.
Human labeling; this does not establish veterinary approval or animal-specific eligibility.
Desyrel is the brand identity; safety facts are drawn from current generic trazodone labeling.
Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.
Adverse effects
Human-label concerns include sedation, dizziness, hypotension, arrhythmia/QT prolongation, hyponatremia and serotonin syndrome; animal incidence is not established.
These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.
Dosing & administration
A verified veterinary dose has not been entered for this product. Human-label dosing must not be used as an animal regimen. Consult a current species-specific clinical source and the prescribing veterinarian.
A veterinary dose is not verified. Confirm release formulation and follow only the individual veterinarian's plan.
Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗
Drug & supplement interactions
This is a selected interaction reference, not an automated or comprehensive combination checker. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.
Desyrel
Human tablet brand identity; Human product
- Other serotonergic drugs increase serotonin-syndrome risk; CNS depressants increase sedation. Review CYP3A4 modifiers, QT-prolonging drugs and anticoagulant/NSAID combinations.
Monitoring
Review cardiac history, coordination, excessive sedation and response; screen serotonergic medicines, MAOIs, CYP3A4 modifiers and CNS depressants.
Client counseling
Report collapse, agitation with tremor/fever, or profound sedation promptly. Avoid unsupervised combination with other behavioral medicines.
This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.
Storage & handling
Keep the labeled product securely away from children and animals; follow its container storage instructions.
Brands, formulations & ingredient identity
Active ingredients
trazodone hydrochloride
Other searchable names: trazodone HCl
Desyrel is a brand identity associated with trazodone hydrochloride tablets. The cited manufacturer lists its generic tablets as the brand equivalent; this does not establish current brand availability.
Confirm immediate-release versus modified-release formulation when reconciling a prescription. A shared ingredient name does not resolve differences in release behavior or instructions.
The salt suffix hydrochloride describes the labeled ingredient, not a second medication.
Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.
Desyrel
- Formulation
- Human tablet brand identity
- Label / product scope
- Human product
Brand synonym retained for lookup; current dispensing availability must be confirmed.
Product label / source ↗References & review status
Clinical reference updated October 16, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.
Search another medication or supplement →